Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SLC18A3 is a member of the vesicular amine transporter family. Additionally we are shipping Solute Carrier Family 18 (Vesicular Acetylcholine), Member 3 Kits (14) and Solute Carrier Family 18 (Vesicular Acetylcholine), Member 3 Proteins (3) and many more products for this protein.
Showing 10 out of 142 products:
Human Polyclonal SLC18A3 Primary Antibody for IEM, ICC - ABIN1526179
Wang, Guan, Ochiai, Nakai: An electron microscopic observation of the vesicular acetylcholine transporter-immunoreactive fibers in the rat dorsal raphe nucleus. in Brain research bulletin 1998
Show all 20 Pubmed References
Mammalian Monoclonal SLC18A3 Primary Antibody for - ABIN1305040
Perez-Gonzalez, Albrecht, Blasi, Llobet: Schwann cells modulate short-term plasticity of cholinergic autaptic synapses. in The Journal of physiology 2008
Show all 6 Pubmed References
Rat (Rattus) Polyclonal SLC18A3 Primary Antibody for IHC, WB - ABIN1742304
Gallart-Palau, Tarabal, Casanovas, Sábado, Correa, Hereu, Piedrafita, Calderó, Esquerda: Neuregulin-1 is concentrated in the postsynaptic subsurface cistern of C-bouton inputs to α-motoneurons and altered during motoneuron diseases. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2014
Show all 4 Pubmed References
Human Polyclonal SLC18A3 Primary Antibody for ICC, IF - ABIN4250912
Li, Yu, Liu, Huang, Abumaria, Zhu, Huang, Xiong, Ren, Liu, Chui, Liu: Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2013
Show all 2 Pubmed References
Human Polyclonal SLC18A3 Primary Antibody for IHC - ABIN926164
Schmidt, Xie, Lyte, Vulchanova, Brown: Autonomic neurotransmitters modulate immunoglobulin A secretion in porcine colonic mucosa. in Journal of neuroimmunology 2007
The results of this study suggest that the Gly360Arg mutant VAChT protein undergoes posttranslational degradation.
PCMC expression of ADAM29 (show ADAM29 Antibodies), FLRT2 (show FLRT2 Antibodies), and SLC18A3 could be assessed as part of a routine screen to help identify individuals at risk of severe Obstructive sleep apnea in Asian populations
Expression of VAChT is increased in neuronal cell lines following upregulation of Lhx8 (show LHX8 Antibodies).
alpha-Synuclein expression in axons to the distal gut (show GUSB Antibodies) correlates closely with expression of the cholinergic marker, VAChT.
Data indicate that siRNA-mediated attenuation of vesicular acetylcholine transporter (VAChT, SLC18A3) reversed the apoptotic activity of vesamicol.
Multiple abnormalities with intellectual and developmental disability result from recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3.
overexpressed ChAT enhanced transcription of the CHT1 (show ChT Antibodies) gene but not the VACHT gene
Mutations in the vesicular acetylcholine transporter demonstrate decreased affinity for acetylcholine and vesamicol.
The colocalisation of CHT1 (show ChT Antibodies) immunoreactivity with VAChT immunoreactivity in cholinergic enteric nerves in the human bowel thus suggests that CHT1 (show ChT Antibodies) represents another marker of cholinergic nerves.
Three non-coding SNPs were detected in SLC18A3. None demonstrated any reproducible association with late-onset AD in our samples.
Aged VAChT-deficient mice showed a decrease in the number of hippocampal neurons and Alzheimer's-Like Pathology.
These findings suggest that nitrosylation of VAChT and VGLUT1 may be associated with dysfunctional acetylcholinergic and glutamatergic neurotransmission in Alzheimer's disease.
Studied object recognition and spatial location in mice deficient for Vesicular Acetylcholine Transporter (VAChT) within interneurons of the striatum, found: impairment in home cage object recognition with a 15 min retention delay, but not with a 3 h retention delay; no on memory for the location of objects; sex differences in retention
VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions. Data demonstrate that increasing levels of acetylcholine at the synaptic cleft promote degeneration of adult neuromuscular junction, contributing to age- and disease-related motor deficits.
Old VAChT deficient mice (13-16 months-old) showed more pronounced motor learning/balance deficits on the rotarod, and more pronounced balance deficits on the catwalk
These results suggest that the VAChT-Cre lines are Cre-drivers that have selectivity in S and FR motor neurons.
Loss of VAChT expression is associated with pulmonary inflammation.
decreased VAChT levels affect synaptic vesicle biogenesis and distribution whereas a lower ACh (show FGFR3 Antibodies) content affects vesicles shape.
we conclude that VAChT overexpression is sufficient to enhance ACh (show FGFR3 Antibodies) release in the hippocampal formation
Data indicate that elimination of VAChT had only marginal consequences in striatum-related tasks and did not affect spontaneous locomotion, cocaine-induced hyperactivity, or its reward properties.
This gene is a member of the vesicular amine transporter family. The encoded transmembrane protein transports acetylcholine into secretory vesicles for release into the extracellular space. Acetylcholine transport utilizes a proton gradient established by a vacuolar ATPase. This gene is located within the first intron of the choline acetyltransferase gene.
, vesicular acetylcholine transporter
, solute carrier family 18 (vesicular acetylcholine), member 3
, vesicular acetylcholine transporter-like
, solute carrier family 18 (vesicular monoamine) member 3
, solute carrier family 18, member 3
, solute carrier family 18 member 3